Please assess the completion status of the following clinical trial:

Trial Title: An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The patient has partial Epilepsy and the diagnosis must be confirmed in the last 6 months~* The patients must be on a stable 1 or 2 anti-epileptic drug(s) treatment during the 4 weeks prior to Baseline and must have at least 8 partial seizures during the 8-week prospective Baseline Period~* Patient at the age of 4 to 16 years, and at the body weight of 11 to 82 kg~Exclusion Criteria:~* The patient has a treatable seizure etiology~* The patient has Epilepsy secondary to a progressive cerebral disease or any other progressively neurodegenerative disease, including Rasmussen and Landau-Kleffner diseases~* The patient has a history of status Epilepticus during the 3 months prior to Visit 1~* The patient has a past and present history of pseudo seizures~* The patient has a current diagnosis of Lennox-Gastaut syndrome

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Levetiracetam (Type: EXPERIMENTAL): Open-label, single-arm

Based on this trial design, predict the completion outcome and termination type (if applicable).